Ziprasidone in the Psychosis Prodrome
What is the purpose of this trial?
This study aims to determine whether ziprasidone is superior to placebo over 24 weeks for patients with the psychosis prodrome.
- 16 Years - 40 Years
- Yale University
- March 2008
- Last Updated:
- May 14, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT00635700